Literature DB >> 11213506

Routine air drying of all smears prepared during fine needle aspiration and intraoperative cytology studies. An opportunity to practice a unified protocol offering the flexibility of choosing a variety of staining methods.

V B Shidham1, B Kampalath, J England.   

Abstract

OBJECTIVE: To evaluate the possibility of routine use of air-dried smears (ADS) instead of wet-fixed smears (WFS). STUDY
DESIGN: Intraoperative cytology (IC) smears from 293 specimens and fine needle aspiration cytology (FNAC) smears from 118 cases were studied. Cytomorphology of ADS processed with our protocol for hematoxylin-eosin (HE) and Papanicolaou (PAP) staining after saline rehydration and postfixation in 95% ethanol with 5% acetic acid were compared with respectively stained WFS. Additional ADS were stored up to 72 hours at room temperature prior to HE, PAP and Diff-Quik (DQ) staining to evaluate the effects of postponing rehydration and postfixation. Special stains for fungi were also studied in four cases.
RESULTS: ADS were easy to prepare without air-drying artifact in the final HE- and PAP-stained smears. ADS were more cellular than WFS. Erythrocyte interference was frequent in WFS. HE and PAP staining of ADS stored up to 72 hours showed cytomorphology comparable to that of the similarly stained fresh smears. However, DQ staining was better if ADS were processed before 24 hours. ADS stained with special stain for fungi showed good morphology, similar to that in WFS.
CONCLUSION: All ADS showed results comparable to or better than WFS. ADS could be stored up to 72 hours before staining with HE and PAP. ADS offers the flexibility of selecting a variety of staining methods and is a practical alternative to WFS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11213506     DOI: 10.1159/000327188

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  9 in total

Review 1.  Immunocytochemistry of effusions: Processing and commonly used immunomarkers.

Authors:  Vinod B Shidham; Beata Janikowski
Journal:  Cytojournal       Date:  2022-01-31       Impact factor: 2.345

2.  Preparation and using phantom lesions to practice fine needle aspiration biopsies.

Authors:  Vinod B Shidham; George M Varsegi; Krista D'Amore; Anjani Shidham
Journal:  J Vis Exp       Date:  2009-09-29       Impact factor: 1.355

3.  Optimization of an immunostaining protocol for the rapid intraoperative evaluation of melanoma sentinel lymph node imprint smears with the 'MCW melanoma cocktail'

Authors:  Vinod B Shidham; Richard Komorowski; Virgilia Macias; Sushma Kaul; Glen Dawson; William W Dzwierzynski
Journal:  Cytojournal       Date:  2004-08-06       Impact factor: 2.091

Review 4.  CellBlockistry: Chemistry and art of cell-block making - A detailed review of various historical options with recent advances.

Authors:  Vinod B Shidham
Journal:  Cytojournal       Date:  2019-06-28       Impact factor: 2.091

Review 5.  Approach to Diagnostic Cytopathology of Serous Effusions.

Authors:  Vinod B Shidham; Lester J Layfield
Journal:  Cytojournal       Date:  2021-12-06       Impact factor: 2.091

Review 6.  Collection and processing of effusion fluids for cytopathologic evaluation.

Authors:  Vinod B Shidham
Journal:  Cytojournal       Date:  2022-01-31       Impact factor: 2.345

Review 7.  Nuances of the Papanicolaou stain.

Authors:  Prajakta Sathawane; Meherbano M Kamal; Pramodini R Deotale; Hirkini Mankar
Journal:  Cytojournal       Date:  2022-06-14       Impact factor: 2.345

8.  A comparative study of cytological processing techniques in hemorrhagic effusion.

Authors:  Poovizhi Inbasekaran; Ramaswamy Anikode Subramanian
Journal:  Cytojournal       Date:  2022-07-11       Impact factor: 2.345

9.  Severe acute respiratory syndrome coronavirus 2 (the cause of COVID 19) in different types of clinical specimens and implications for cytopathology specimen: An editorial review with recommendations.

Authors:  Vinod B Shidham; Nora K Frisch; Lester J Layfield
Journal:  Cytojournal       Date:  2020-04-10       Impact factor: 2.091

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.